Rashtriya Newsflash

Night Vision Disturbances Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Opus Genetics, Viatris, Nevakar, Vyluma, Pfizer, Allergan, AbbVie

Night Vision Disturbances Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Opus Genetics, Viatris, Nevakar, Vyluma, Pfizer, Allergan, AbbVie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Night Vision Disturbances pipeline constitutes key companies continuously working towards developing Night Vision Disturbances treatment therapies, analysis of Clinical Trials,

Read Full Article

NK Cell Therapy Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Amgen, ImmunityBio, Dragonfly Therapeutics, Glycostem Therapeutics, Athenex, Artiva Biotherap

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, NK Cell Therapy pipeline constitutes 140+ key companies continuously working towards developing 160+ Nk Cell Therapy treatment therapies, analysis of

Read Full Article

Primary Myelofibrosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Primary Myelofibrosis pipeline constitutes 55+ key companies continuously working towards developing 55+ Primary Myelofibrosis treatment therapies, analysis of Clinical Trials,

Read Full Article

Intratumoral Cancer Therapies Market: Expanding Revenue Landscape to 2034 – DelveInsight | Amgen, Daiichi Sankyo, AiViva BioPharma, Lytix Biopharma, Regeneron Pharma, Checkmate Pharma, Replimune

The Key Intratumoral Cancer Therapies Companies in the market include – Amgen, Daiichi Sankyo, AiViva BioPharma, Lytix Biopharma, Regeneron Pharmaceuticals, Checkmate Pharmaceuticals, OncoSec Medical Incorporated, Merck, Istari Oncology, Replimune, Philogen,

Read Full Article

Platform as a Service Market Set to Reach USD 344.4 Billion by 2031 Driven by Cloud-Native Development & Multi-Cloud Adoption

Platform as a Service Market Mordor Intelligence has published a new report on the platform as a service market, offering

Read Full Article

Chia Seeds Market Size to Reach USD 1.41 Billion by 2031, Supported by Plant-Based Nutrition Demand, Organic Premiumization, and Functional Food Expansion

Chia Seeds Market Size & Trends | Mordor Intelligence Explore the chia seeds market (2026–2031) with Mordor Intelligence. Get in-depth

Read Full Article

Global Obesity Pipeline Surges as 80+ Pharma Players Intensify Clinical Trials, Paving the Way for Next-Gen Weight Loss Therapies | DelveInsight

Obesity Pipelin Leading Obesity Companies include Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer,

Read Full Article

Myelodysplastic Syndrome Pipeline Surges as 120+ Pharma Players Accelerate Clinical Innovation and Transform Treatment Landscape by 2034 | DelveInsight

Myelodysplastic Syndrome Pipeline Leading Myelodysplastic Syndrome Companies such as Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen,

Read Full Article

Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight

As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards developing 20+ Hemophilia B treatment

Read Full Article

Tax IQ Academy Launches Nationwide Tax Training Program – Florida Summer Jam Session Set for May 2026

Orlando, FL – April 9, 2026 – Tax IQ Academy, a leading provider of IRS-approved tax education, is proud to

Read Full Article